Kawasaki, Japan

Morikazu Kito


Average Co-Inventor Count = 6.9

ph-index = 5

Forward Citations = 61(Granted Patents)


Location History:

  • Kanagawa, JP (2003)
  • Kawasaki, JP (1999 - 2012)

Company Filing History:


Years Active: 1999-2012

Loading Chart...
16 patents (USPTO):Explore Patents

Title: Morikazu Kito: Innovator in Drug Development

Introduction

Morikazu Kito is a prominent inventor based in Kawasaki, Japan. He has made significant contributions to the field of drug development, holding a total of 16 patents. His work focuses on identifying target proteins and genes that can lead to the discovery of novel pharmaceuticals.

Latest Patents

Kito's latest patents include innovative methods for drug discovery. One of his notable inventions involves a novel target protein and target gene for drug development. This invention provides essential tools for screening potential drugs, particularly for central nervous diseases. Additionally, he has developed methods for producing drug derivatives and kits for determining disease susceptibility. Another significant patent focuses on CARP proteins and genes, which are crucial for creating antiallergic drugs and regulating allergic diseases.

Career Highlights

Throughout his career, Morikazu Kito has worked with esteemed organizations such as Ajinomoto Co., Ltd. and Reverse Proteomics Research Institute Co., Ltd. His experience in these companies has allowed him to advance his research and contribute to the pharmaceutical industry significantly.

Collaborations

Kito has collaborated with notable colleagues, including Naoyuki Fukuchi and Hiroshi Yamamoto. These partnerships have further enriched his research and innovation in drug development.

Conclusion

Morikazu Kito's contributions to drug development through his patents and collaborations highlight his role as a key innovator in the pharmaceutical field. His work continues to pave the way for advancements in drug discovery and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…